Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat

Altman, 1999, Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice, Mol. Pharmacol., 56, 154, 10.1124/mol.56.1.154 Arnsten, 2000, Genetics of childhood disorders: XVIII. ADHD, part. 2: norepinephrine has a critical modulatory influence on prefrontal cortical function, J. Am. Acad. Child Adolesc. Psychiatry, 39, 201, 10.1097/00004583-200009000-00022 Arnsten, 1985, Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates, Science, 230, 1273, 10.1126/science.2999977 Arnsten, 1996, The contribution of alpha-2 noradrenergic mechanisms of prefrontal cortical cognitive function: potential significance for attention deficit hyperactivity disorder, Arch. Gen. Psychiatry, 53, 448, 10.1001/archpsyc.1996.01830050084013 Biederman, 2005, Attention-deficit/hyperactivity disorder: a selective overview, Biol. Psychiatry, 57, 1215, 10.1016/j.biopsych.2004.10.020 Biederman, 2002, Current concepts on the neurobiology of attention-deficit/hyperactivity disorder, J. Atten. Disord., 6, S7, 10.1177/070674370200601S03 Biederman, 1999, Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder, Biol. Psychiatry, 46, 1234, 10.1016/S0006-3223(99)00192-4 Blier, 1998, Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission, Ann. N.Y. Acad. Sci., 861, 204, 10.1111/j.1749-6632.1998.tb10192.x Bymaster, 2002, Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder, Neuropsychopharmacology, 27, 699, 10.1016/S0893-133X(02)00346-9 Castellanos, 1996, Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder, Arch. Gen. Psychiatry, 53, 607, 10.1001/archpsyc.1996.01830070053009 Czachura, 2000, Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat, Naunyn Schmiedebergs Arch. Pharmacol., 362, 266, 10.1007/s002100000290 Dalley, 2004, Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates, Neurosci. Biobehav. Rev., 28, 771, 10.1016/j.neubiorev.2004.09.006 Franowicz, 2002, Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine, J. Neurosci., 22, 8771, 10.1523/JNEUROSCI.22-19-08771.2002 Gasior, 2005, Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys, Neuropsychopharmacology, 30, 758, 10.1038/sj.npp.1300593 Gehlert, 1995, Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain, Neurochem. Int., 26, 47, 10.1016/0197-0186(94)00113-9 Giedd, 2001, Brain imaging of attention deficit/hyperactivity disorder, Ann. N.Y. Acad. Sci., 931, 33, 10.1111/j.1749-6632.2001.tb05772.x Heil, 2002, Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users, Drug Alcohol Depend., 67, 149, 10.1016/S0376-8716(02)00053-4 Hynd, 1990, Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity, Arch. Neurol., 47, 919, 10.1001/archneur.1990.00530080107018 Koch, 2002, R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study, Neuropsychopharmacology, 27, 949, 10.1016/S0893-133X(02)00377-9 Leibowitz, 1970, Reciprocal hunger-regulating circuits involving alpha- and beta-adrenergic receptors located, respectively, in the ventromedial and lateral hypothalamus, Proc. Natl Acad. Sci. U.S.A., 67, 1063, 10.1073/pnas.67.2.1063 Li, 1998, Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum, Psychopharmacology, 136, 153, 10.1007/s002130050551 Lindvall, 1978, Organization of catecholamine neurons projecting to the frontal cortex in the rat, Brain Res., 142, 1, 10.1016/0006-8993(78)90173-7 Ma, 2005, Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys, Biol. Psychiatry, 57, 192, 10.1016/j.biopsych.2004.11.004 Michelson, 2002, Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study, Am. J. Psychiatry, 159, 1896, 10.1176/appi.ajp.159.11.1896 Paxinos, 1986 Pliszka, 1996, Catecholamines in attention-deficit hyperactivity disorder: current perspectives, J. Am. Acad. Child Adolesc. Psychiatry, 35, 264, 10.1097/00004583-199603000-00006 Rueter, 1998, Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems, J. Pharmacol. Exp. Ther., 285, 404 Rubia, 1999, Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI, Am. J. Psychiatry, 156, 891, 10.1176/ajp.156.6.891 Sacchetti, 2001, Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors, Naunyn Schmiedebergs Arch. Pharmacol., 363, 66, 10.1007/s002100000334 Sacchetti, 1999, Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain, Br. J. Pharmacol., 128, 1332, 10.1038/sj.bjp.0702926 Schneider, 1990, Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys, Brain Res., 519, 122, 10.1016/0006-8993(90)90069-N Scheibner, 2001, Stimulation frequency-noradrenaline release relationships examined in alpha2A-, alpha2B- and alpha2C-adrenoceptor-deficient mice, Naunyn Schmiedebergs Arch. Pharmacol., 364, 321, 10.1007/s002100100432 Sesack, 1998, Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter, J. Neurosci., 18, 2697, 10.1523/JNEUROSCI.18-07-02697.1998 Soucy, 1997, Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain, Synapse, 25, 163, 10.1002/(SICI)1098-2396(199702)25:2<163::AID-SYN7>3.0.CO;2-A Valentini, 2004, Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine, J. Neurochem., 88, 917, 10.1046/j.1471-4159.2003.02238.x Wee, 2004, Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine, Drug Alcohol Depend., 75, 271, 10.1016/j.drugalcdep.2004.03.010 Wong, 1982, A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain, J. Pharmacol. Exp. Ther., 222, 61 Zametkin, 1987, Noradrenergic hypothesis of attention deficit disorder with hyperactivity: a critical review, 837